Chris Dye

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. doi request reprint Health and urban living
    Christopher Dye
    World Health Organization, 1211 Geneva 27, Switzerland
    Science 319:766-9. 2008
  2. pmc The resurgence of tuberculosis in Russia
    M V Shilova
    Department of Epidemiology and Antituberculosis Care Organization, Research Institute of Phthisiopulmonology, I. M. Setchenov Medical Academy, 4 Dostoevsky Street, 101478 Moscow, Russian Federation
    Philos Trans R Soc Lond B Biol Sci 356:1069-75. 2001
  3. pmc Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered
    Christopher Dye
    World Health Organization, Avenue Appia, CH1211 Geneva 27, Switzerland
    J R Soc Interface 10:20130365. 2013
  4. doi request reprint Prospects for tuberculosis elimination
    Christopher Dye
    Office of Health Information, World Health Organization, CH 1211 Geneva 27, Switzerland
    Annu Rev Public Health 34:271-86. 2013
  5. doi request reprint WHO and the future of disease control programmes
    Christopher Dye
    HIV AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases Cluster, World Health Organization, CH 1211 Geneva 27, Switzerland
    Lancet 381:413-8. 2013
  6. pmc National and international policies to mitigate disease threats
    Christopher Dye
    HIV AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases, World Health Organization, Avenue Appia 20, CH 1211 Geneva 27, Switzerland
    Philos Trans R Soc Lond B Biol Sci 367:2893-900. 2012
  7. pmc The potential impact of new diagnostic tests on tuberculosis epidemics
    Christopher Dye
    HIV AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases Cluster, World Health Organization, Geneva, Switzerland
    Indian J Med Res 135:737-44. 2012
  8. pmc Highly active antiretroviral treatment for the prevention of HIV transmission
    Reuben Granich
    Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    J Int AIDS Soc 13:1. 2010
  9. pmc Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence
    Catherine R Stevenson
    Medical Research Council Epidemiology Unit, Cambridge, UK
    BMC Public Health 7:234. 2007
  10. pmc Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence
    Christine S M Currie
    School of Mathematics, University of Southampton, Southampton, SO17 1BJ, UK
    BMC Public Health 5:130. 2005

Detail Information

Publications72

  1. doi request reprint Health and urban living
    Christopher Dye
    World Health Organization, 1211 Geneva 27, Switzerland
    Science 319:766-9. 2008
    ..Subject to better evidence, I suggest that the main obstacles to improving urban health are not technical or even financial, but rather are related to governance and the organization of civil society...
  2. pmc The resurgence of tuberculosis in Russia
    M V Shilova
    Department of Epidemiology and Antituberculosis Care Organization, Research Institute of Phthisiopulmonology, I. M. Setchenov Medical Academy, 4 Dostoevsky Street, 101478 Moscow, Russian Federation
    Philos Trans R Soc Lond B Biol Sci 356:1069-75. 2001
    ..Although our explanation for the resurgence of TB is incomplete, we have identified a set of measures that can be implemented now to cut transmission, incidence and deaths...
  3. pmc Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered
    Christopher Dye
    World Health Organization, Avenue Appia, CH1211 Geneva 27, Switzerland
    J R Soc Interface 10:20130365. 2013
    ..These findings suggest, subject to further evaluation, that BCG revaccination could be cost-effective in some settings. ..
  4. doi request reprint Prospects for tuberculosis elimination
    Christopher Dye
    Office of Health Information, World Health Organization, CH 1211 Geneva 27, Switzerland
    Annu Rev Public Health 34:271-86. 2013
    ..An important milestone en route to elimination will be reached when there is less than 1 TB death per 100,000 population, marking entry into the elimination phase. This landmark can be reached by many countries within 1-2 decades...
  5. doi request reprint WHO and the future of disease control programmes
    Christopher Dye
    HIV AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases Cluster, World Health Organization, CH 1211 Geneva 27, Switzerland
    Lancet 381:413-8. 2013
    ..Among a multiplicity of actors, WHO's task is to enhance its normative role as convenor, coordinator, monitor, and standard-setter, fostering greater coherence in global health...
  6. pmc National and international policies to mitigate disease threats
    Christopher Dye
    HIV AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases, World Health Organization, Avenue Appia 20, CH 1211 Geneva 27, Switzerland
    Philos Trans R Soc Lond B Biol Sci 367:2893-900. 2012
    ..All these things considered, this paper is a brief policy-making guide by example, illustrating some achievements and disappointments with reference to cholera, drug-resistant tuberculosis, HIV/AIDS and rabies...
  7. pmc The potential impact of new diagnostic tests on tuberculosis epidemics
    Christopher Dye
    HIV AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases Cluster, World Health Organization, Geneva, Switzerland
    Indian J Med Res 135:737-44. 2012
    ..In this study we use mathematical modelling to explore the potential epidemiological impact of these new tests, with particular reference to India...
  8. pmc Highly active antiretroviral treatment for the prevention of HIV transmission
    Reuben Granich
    Department of HIV AIDS, World Health Organization, Geneva, Switzerland
    J Int AIDS Soc 13:1. 2010
    ..To explore HAART as a prevention strategy, we recommend further discussions to explore human rights and ethical considerations, clarify research priorities and review feasibility and acceptability issues...
  9. pmc Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence
    Catherine R Stevenson
    Medical Research Council Epidemiology Unit, Cambridge, UK
    BMC Public Health 7:234. 2007
    ..Diabetes increases the risk of TB. Our aim was to assess the potential impact of diabetes as a risk factor for incident pulmonary tuberculosis, using India as an example...
  10. pmc Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence
    Christine S M Currie
    School of Mathematics, University of Southampton, Southampton, SO17 1BJ, UK
    BMC Public Health 5:130. 2005
    ..However, published cost and cost-effectiveness studies are limited...
  11. pmc Alcohol use as a risk factor for tuberculosis - a systematic review
    Knut Lonnroth
    Stop TB Department, World Health Organization, Geneva, Switzerland
    BMC Public Health 8:289. 2008
    ..Nor has the strength of the association been established. The objective of this study was to systematically review the available evidence on the association between alcohol use and the risk of tuberculosis...
  12. pmc Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007
    Ryuichi Komatsu
    The Global Fund to Fight AIDS, Tuberculosis and Malaria, Chemin Blandonnet 8, 1214 Vernier, Geneva, Switzerland
    BMC Infect Dis 10:109. 2010
    ..This paper presents and discusses a methodology for estimating the lives saved through selected service deliveries reported to the Global Fund...
  13. doi request reprint Measuring tuberculosis burden, trends, and the impact of control programmes
    C Dye
    HIV AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland
    Lancet Infect Dis 8:233-43. 2008
    ..By 2015, every country should be able to assess progress in tuberculosis control by estimating the time trend in incidence, and the magnitude of reductions in either prevalence or deaths...
  14. ncbi request reprint The decline of tuberculosis epidemics under chemotherapy: a case study in Morocco
    C Dye
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Int J Tuberc Lung Dis 11:1225-31. 2007
    ..At the current pace of epidemic decline, there will be more than 10,000 new cases in 2050, the target year for global elimination...
  15. pmc Eliminating human tuberculosis in the twenty-first century
    Christopher Dye
    HIV AIDS, Tuberculosis and Malaria, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland
    J R Soc Interface 5:653-62. 2008
    ..Our results should be a stimulus to those who develop, manufacture and implement new technology for TB control, and to their financial donors...
  16. pmc Did we reach the 2005 targets for tuberculosis control?
    Christopher Dye
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Bull World Health Organ 85:364-9. 2007
    ....
  17. ncbi request reprint Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally
    Christopher Dye
    Stop TB Department, World Health Organization, Geneva, Switzerland
    JAMA 293:2767-75. 2005
    ....
  18. ncbi request reprint Targets for global tuberculosis control
    C Dye
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Int J Tuberc Lung Dis 10:460-2. 2006
    ..This paper reviews the history of target setting for TB control and lays out the complete set of indicators and targets that will guide TB control through to 2015, the target year for all MDGs...
  19. ncbi request reprint Global epidemiology of tuberculosis
    Christopher Dye
    HIV AIDS, Tuberculosis and Malaria, WHO, CH 1211 Geneva 27, Switzerland
    Lancet 367:938-40. 2006
  20. ncbi request reprint Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis
    Christopher Dye
    Communicable Diseases, World Health Organization, CH 1211 Geneva 27, Switzerland
    Science 295:2042-6. 2002
    ....
  21. pmc Will tuberculosis become resistant to all antibiotics?
    C Dye
    Communicable Diseases, World Health Organization, Geneva, Switzerland
    Proc Biol Sci 268:45-52. 2001
    ..To substantiate this result, further measurements are needed of the relative fitness of drug-resistant strains...
  22. ncbi request reprint Worldwide incidence of multidrug-resistant tuberculosis
    Christopher Dye
    Communicable Diseases, World Health Organization, 1211 Geneva 27, Switzerland
    J Infect Dis 185:1197-202. 2002
    ..2% of all new TB cases. The analysis provides the first comprehensive set of estimates of the MDR TB burden by country and globally...
  23. pmc Nutrition, diabetes and tuberculosis in the epidemiological transition
    Christopher Dye
    HIV AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland
    PLoS ONE 6:e21161. 2011
    ..Interactions between diabetes and BMI could help or hinder TB control in growing, aging, urbanizing populations...
  24. doi request reprint The population dynamics and control of tuberculosis
    Christopher Dye
    World Health Organization, CH1211 Geneva 27, Switzerland
    Science 328:856-61. 2010
    ..Whatever the technology used, success depends critically on the social, institutional, and epidemiological context in which it is applied...
  25. doi request reprint Slow elimination of multidrug-resistant tuberculosis
    Christopher Dye
    Office of HIV AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases, World Health Organization, CH1211 Geneva 27, Switzerland
    Sci Transl Med 1:3ra8. 2009
    ..This result applies even to countries such as Estonia and Latvia, which have exceptionally high prevalence rates of multidrug-resistant tuberculosis...
  26. ncbi request reprint What is the limit to case detection under the DOTS strategy for tuberculosis control?
    Christopher Dye
    Communicable Diseases, World Health Organization, 1211 Geneva 27, Switzerland
    Tuberculosis (Edinb) 83:35-43. 2003
    ....
  27. ncbi request reprint Epidemiology. Modeling the SARS epidemic
    Chris Dye
    Communicable Diseases, World Health Organization, 1211 Geneva 27, Switzerland
    Science 300:1884-5. 2003
  28. pmc Trends in tuberculosis incidence and their determinants in 134 countries
    C Dye
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Bull World Health Organ 87:683-91. 2009
    ..To determine whether differences in national trends in tuberculosis incidence are attributable to the variable success of control programmes or to biological, social and economic factors...
  29. doi request reprint Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis
    Christopher Dye
    World Health Organization, Geneva 27, Switzerland
    Nat Rev Microbiol 7:81-7. 2009
    ..Recent data suggest that national TB control programmes that use existing drugs efficiently can postpone and even reverse epidemics of multidrug-resistant TB, although the effect of such programmes on XDR strains remains largely unknown...
  30. pmc Planning to improve global health: the next decade of tuberculosis control
    Dermot Maher
    Stop TB Department, WHO, Geneva, Switzerland
    Bull World Health Organ 85:341-7. 2007
    ..This approach to planning for global tuberculosis control is a valuable example of developing plans to improve global health that has relevance for other health issues...
  31. ncbi request reprint Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries
    M A Espinal
    World Health Organization, Communicable Diseases Programme, Ave Appia 20, 1211 Geneva 27, Switzerland
    JAMA 283:2537-45. 2000
    ....
  32. ncbi request reprint Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project
    C Dye
    Communicable Diseases Prevention and Control, World Health Organization, Geneva, Switzerland
    JAMA 282:677-86. 1999
    ..To estimate the risk and prevalence of Mycobacterium tuberculosis (MTB) infection and tuberculosis (TB) incidence, prevalence, and mortality, including disease attributable to human immunodeficiency virus (HIV), for 212 countries in 1997...
  33. pmc Criteria for the control of drug-resistant tuberculosis
    C Dye
    Communicable Disease Control, Prevention and Eradication, World Health Organization, CH 1211 Geneva 27, Switzerland
    Proc Natl Acad Sci U S A 97:8180-5. 2000
    ..We discuss the implications of these results for World Health Organization policy on the management of antibiotic resistance...
  34. ncbi request reprint The design effect and cluster samples: optimising tuberculosis prevalence surveys
    B Williams
    World Health Organization, Geneva, Switzerland
    Int J Tuberc Lung Dis 12:1110-5. 2008
    ..We illustrate the results using data from a recent survey in Cambodia in which TB was diagnosed using sputum smears, cultures and X-rays...
  35. ncbi request reprint Tuberculosis prevalence surveys: rationale and cost
    P Glaziou
    World Health Organization, Regional Office for the Western Pacific, Manila, Philippines
    Int J Tuberc Lung Dis 12:1003-8. 2008
    ..The cost of a prevalence survey is typically US$ 4-15 per person surveyed, and up to US$ 25 per person with radiographic screening. A survey of 50,000 people, of limited precision, would typically cost US$ 200,000-1,250,000...
  36. ncbi request reprint Assessment of worldwide tuberculosis control. WHO Global Surveillance and Monitoring Project
    M C Raviglione
    Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland
    Lancet 350:624-9. 1997
    ....
  37. ncbi request reprint Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance
    M A Espinal
    Communicable Diseases Cluster, World Health Organization, Geneva, Switzerland
    N Engl J Med 344:1294-303. 2001
    ..Data on global trends in resistance to antituberculosis drugs are lacking...
  38. pmc The impact of HIV/AIDS on the control of tuberculosis in India
    B G Williams
    World Health Organization, 20 Avenue Appia, Geneva 1212, Switzerland
    Proc Natl Acad Sci U S A 102:9619-24. 2005
    ....
  39. ncbi request reprint Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy
    C Dye
    Global Tuberculosis Programme, WHO, Geneva, Switzerland
    Lancet 352:1886-91. 1998
    ..WHO advocates the use of directly observed treatment with a short-course drug regimen as part of the DOTS strategy, but the potential effect of this strategy worldwide has not been investigated...
  40. ncbi request reprint Tuberculosis 2000-2010: control, but not elimination
    C Dye
    Communicable Diseases Control, Prevention and Eradication, World Health Organization, Geneva, Switzerland
    Int J Tuberc Lung Dis 4:S146-52. 2000
    ..Even if morbidity and mortality are significantly reduced before 2010, tuberculosis infection will persist for much longer, acting as a sensitive indicator of public health, and as a marker of the quality of health services...
  41. ncbi request reprint The measurement and estimation of tuberculosis mortality
    E L Korenromp
    The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland
    Int J Tuberc Lung Dis 13:283-303. 2009
    ....
  42. ncbi request reprint Tuberculosis deaths in countries with high HIV prevalence: what is their use as an indicator in tuberculosis programme monitoring and epidemiological surveillance?
    D Maher
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Int J Tuberc Lung Dis 9:123-7. 2005
    ....
  43. ncbi request reprint Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review
    Eline L Korenromp
    Communicable Diseases, Stop TB Department, World Health Organization, Geneva, Switzerland
    Clin Infect Dis 37:101-12. 2003
    ..025). In countries where HIV infection is endemic, TB recurrence may be reduced by administration of rifampin-based treatment for at least 6 months, in accordance with World Health Organization recommendations...
  44. ncbi request reprint Monitoring mosquito net coverage for malaria control in Africa: possession vs. use by children under 5 years
    Eline L Korenromp
    World Health Organization, Roll Back Malaria Monitoring and Evaluation, Geneva, Switzerland
    Trop Med Int Health 8:693-703. 2003
    ..To investigate the strengths and weaknesses of the indicators 'proportion of households possessing mosquito net(s)' and 'proportion of children under 5 years of age who slept under a net the preceding night' for monitoring malaria control...
  45. ncbi request reprint Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS
    Brian G Williams
    Communicable Diseases, World Health Organization, 1211 Geneva 27, Switzerland
    Science 301:1535-7. 2003
    ..However, ARV drugs could enhance the treatment of TB, and TB programs provide an important entry point for the treatment of HIV/AIDS...
  46. ncbi request reprint Tuberculosis
    Thomas R Frieden
    New York City Department of Health and Mental Hygiene, New York, NY 10013, USA
    Lancet 362:887-99. 2003
    ..Until tuberculosis is controlled worldwide, it will continue to be a major killer in less-developed countries and a constant threat in most of the more-developed countries...
  47. ncbi request reprint The development and impact of tuberculosis vaccines
    Douglas Young
    Imperial College, University of London, South Kensington Campus, London SW7 2AZ, United Kingdom
    Cell 124:683-7. 2006
    ..But developing a new effective vaccine will require innovation in scientific research, a proactive approach to clinical trials of new vaccine candidates, and application of vaccines as part of an integrated approach to disease control...
  48. ncbi request reprint Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy
    Eline L Korenromp
    Malaria Control Department of WHO, Geneva, Switzerland
    Lancet Infect Dis 3:349-58. 2003
    ....
  49. ncbi request reprint Public health. A National Tuberculosis Archive
    Damian Gessler
    National Center for Genome Resources, Santa Fe, NM 87505, USA
    Science 311:1245-6. 2006
  50. ncbi request reprint The growing burden of tuberculosis: global trends and interactions with the HIV epidemic
    Elizabeth L Corbett
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, England, UK
    Arch Intern Med 163:1009-21. 2003
    ..The increasing global burden of tuberculosis (TB) is linked to human immunodeficiency virus (HIV) infection...
  51. pmc Low access to a highly effective therapy: a challenge for international tuberculosis control
    Christopher Dye
    Communicable Diseases, World Health Organization, Geneva, Switzerland
    Bull World Health Organ 80:437-44. 2002
    ....
  52. ncbi request reprint Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru
    Pedro G Suarez
    National Tuberculosis Control Programme, Ministry of Health, Lima, Peru
    Lancet 359:1980-9. 2002
    ....
  53. ncbi request reprint Estimates of world-wide distribution of child deaths from acute respiratory infections
    Brian G Williams
    World Health Organization, 20 Avenue Appia, Geneva 27, CH 1211, Switzerland
    Lancet Infect Dis 2:25-32. 2002
    ..This analysis suggests that throughout the world 1.9 million (95% CI 1.6-2.2 million) children died from ARI in 2000, 70% of them in Africa and southeast Asia...
  54. ncbi request reprint Tuberculosis epidemics driven by HIV: is prevention better than cure?
    Christine S M Currie
    Faculty of Mathematical Studies, University of Southampton, Southampton, UK
    AIDS 17:2501-8. 2003
    ..To compare the benefits of tuberculosis (TB) treatment with TB and HIV prevention for the control of TB in regions with high HIV prevalence...
  55. pmc Breaking a law: tuberculosis disobeys Styblo's rule
    Christopher Dye
    Bull World Health Organ 86:4. 2008
  56. ncbi request reprint HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations
    Brian G Williams
    Stop TB Department, World Health Organization, Geneva 1211 CH 1211, Switzerland
    J Infect Dis 194:1450-8. 2006
    ....
  57. ncbi request reprint Global incidence of multidrug-resistant tuberculosis
    Matteo Zignol
    Stop TB Department, World Health Organization, Geneva 1211, Switzerland
    J Infect Dis 194:479-85. 2006
    ....
  58. ncbi request reprint Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration
    Alasdair Reid
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet Infect Dis 6:483-95. 2006
    ....
  59. ncbi request reprint India's leading role in tuberculosis epidemiology & control
    Christopher Dye
    Indian J Med Res 123:481-4. 2006
  60. ncbi request reprint Tuberculosis control in the era of HIV
    Paul Nunn
    Stop TB Department, World Health Organization, Via Appia 27, CH 1211, Geneva 12, Switzerland
    Nat Rev Immunol 5:819-26. 2005
    ..As a consequence, global TB control policies have had to be revised and control of TB now demands increased investment. This paper assesses what is being done to address the issue and what remains to be done...
  61. ncbi request reprint Reducing the global burden of tuberculosis: the contribution of improved diagnostics
    Emmett Keeler
    RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, California 90407 2138, USA
    Nature 444:49-57. 2006
  62. pmc Financing tuberculosis control: the role of a global financial monitoring system
    Katherine Floyd
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Bull World Health Organ 85:334-40. 2007
    ..We also analyse the strengths and limitations of the system and its relevance to other health-care programmes...
  63. ncbi request reprint Can DOTS control multidrug-resistant tuberculosis?
    Marcos A Espinal
    Stop TB Partnership, World Health Organization, CH 1211 Geneva, Switzerland
    Lancet 365:1206-9. 2005
  64. pmc Monitoring global health: WHO has mandate and expertise
    Christopher Dye
    BMJ 330:195. 2005
  65. ncbi request reprint The science of social diseases
    Christopher Dye
    Science 307:181. 2005
  66. pmc Cost effectiveness analysis of strategies for tuberculosis control in developing countries
    Rob Baltussen
    Institute for Medical Technology Assessment iMTA, Erasmus Medical Centre, PO Box 1738, 3000 DR Rotterdam, Netherlands
    BMJ 331:1364. 2005
    ..To assess the costs and health effects of tuberculosis control interventions in Africa and South East Asia in the context of the millennium development goals...
  67. ncbi request reprint Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners
    Elizabeth L Corbett
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom
    Am J Respir Crit Care Med 170:673-9. 2004
    ..The difference in mean duration of smear positivity was particularly marked and, if generalizable, will have major implications for TB control prospects in high HIV prevalence areas...
  68. pmc The potential impact of male circumcision on HIV in Sub-Saharan Africa
    Brian G Williams
    World Health Organization, Stop TB Department, Geneva, Switzerland
    PLoS Med 3:e262. 2006
    ..We explore the implications of this finding for the promotion of MC as a public health intervention to control HIV in sub-Saharan Africa...
  69. ncbi request reprint Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission
    Orin Courtenay
    Ecology and Epidemiology Group, Department of Biological Sciences, University of Warwick, Coventry, United Kingdom
    J Infect Dis 186:1314-20. 2002
    ..Mathematical modeling suggests that culling programs fail because of high incidence of infection and infectiousness, the insensitivity of the diagnostic test to detect infectious dogs, and time delays between diagnosis and culling...
  70. ncbi request reprint A booster for tuberculosis vaccines
    Christopher Dye
    JAMA 291:2127-8. 2004
  71. ncbi request reprint Diabetes and the risk of tuberculosis: a neglected threat to public health?
    Catherine R Stevenson
    Medical Research Council Epidemiology Unit, Elsie Widdowson Laboratory, Fulbourn Road, Cambridge CB1 9NL, UK
    Chronic Illn 3:228-45. 2007
    ..However, this is rarely highlighted in current research or control priorities. This paper aims to evaluate the evidence for an association between these two diseases...
  72. doi request reprint Modeling the impact of immigration on the epidemiology of tuberculosis
    Zhong Wei Jia
    School of Information Engineering, Beijing University of Posts and Telecommunications, 10 Xitucheng Road, Beijing 100876, PR China
    Theor Popul Biol 73:437-48. 2008
    ..This finding is also supported by numerical simulations with the extended model. Our study suggests that immigrants have a considerable influence on the overall transmission dynamics behavior of tuberculosis...